USD 145.14
(-0.83%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 383.73 Million USD | 0.33% |
2022 | 382.47 Million USD | 0.03% |
2021 | 382.37 Million USD | 41.2% |
2020 | 270.81 Million USD | 272.86% |
2019 | 72.63 Million USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | -100.0% |
2015 | 765 Thousand USD | -91.47% |
2014 | 8.96 Million USD | -48.75% |
2013 | 17.5 Million USD | 0.0% |
2012 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 56.69 Million USD | -79.98% |
2024 Q1 | 283.11 Million USD | 0.12% |
2024 Q3 | 157.12 Million USD | 0.12% |
2023 Q3 | 383.78 Million USD | -0.02% |
2023 Q1 | 383.24 Million USD | 0.2% |
2023 Q2 | 383.88 Million USD | 0.17% |
2023 Q4 | 383.73 Million USD | -0.01% |
2023 FY | 383.73 Million USD | 0.33% |
2022 Q4 | 382.47 Million USD | -0.01% |
2022 Q2 | 382.53 Million USD | 0.07% |
2022 Q3 | 382.5 Million USD | -0.01% |
2022 Q1 | 382.26 Million USD | -0.03% |
2022 FY | 382.47 Million USD | 0.03% |
2021 Q1 | 81.51 Million USD | -69.9% |
2021 FY | 382.37 Million USD | 41.2% |
2021 Q4 | 382.37 Million USD | 0.0% |
2021 Q3 | 382.37 Million USD | 310.96% |
2021 Q2 | 93.04 Million USD | 14.14% |
2020 Q3 | 266.11 Million USD | 3.25% |
2020 Q4 | 270.81 Million USD | 1.77% |
2020 FY | 270.81 Million USD | 272.86% |
2020 Q1 | 72.91 Million USD | 0.4% |
2020 Q2 | 257.73 Million USD | 253.47% |
2019 Q4 | 72.63 Million USD | -9.5% |
2019 Q1 | 12.17 Million USD | 0.0% |
2019 Q3 | 80.25 Million USD | 0.49% |
2019 Q2 | 79.86 Million USD | 556.04% |
2019 FY | 72.63 Million USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q1 | - USD | -100.0% |
2016 FY | - USD | -100.0% |
2016 Q3 | - USD | 0.0% |
2015 Q1 | 13.7 Million USD | 52.79% |
2015 Q2 | 11.63 Million USD | -15.06% |
2015 FY | 765 Thousand USD | -91.47% |
2015 Q4 | 765 Thousand USD | -74.83% |
2015 Q3 | 3.03 Million USD | -73.89% |
2014 Q1 | 15.4 Million USD | -11.96% |
2014 FY | 8.96 Million USD | -48.75% |
2014 Q4 | 8.96 Million USD | 0.0% |
2014 Q2 | 13.28 Million USD | -13.76% |
2013 FY | 17.5 Million USD | 0.0% |
2013 Q4 | 17.5 Million USD | 0.0% |
2013 Q3 | 17.5 Million USD | 0.0% |
2012 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Abbott Laboratories | 13.59 Billion USD | 97.178% |
Allurion Technologies Inc. | 2.3 Million USD | -16540.85% |
Artivion, Inc. | 305.53 Million USD | -25.597% |
Avanos Medical, Inc. | 159.4 Million USD | -140.739% |
Butterfly Network, Inc. | 22.83 Million USD | -1580.482% |
Butterfly Network, Inc. | 22.83 Million USD | -1580.482% |
Bio-Rad Laboratories, Inc. | 1.18 Billion USD | 67.738% |
Boston Scientific Corporation | 8.96 Billion USD | 95.718% |
Perspective Therapeutics, Inc. | - USD | -Infinity% |
CONMED Corporation | 971.48 Million USD | 60.5% |
Edwards Lifesciences Corporation | 670 Million USD | 42.726% |
Paragon 28, Inc. | 109.79 Million USD | -249.491% |
Globus Medical, Inc. | 417.4 Million USD | 8.065% |
Inspire Medical Systems, Inc. | 24.84 Million USD | -1444.466% |
Integer Holdings Corporation | 959.92 Million USD | 60.024% |
Medtronic plc | 23.87 Billion USD | 98.393% |
Nevro Corp. | 211.47 Million USD | -81.461% |
Owlet, Inc. | 22 Thousand USD | -1744163.636% |
Penumbra, Inc. | 220.9 Million USD | -73.709% |
Vicarious Surgical Inc. | 13.78 Million USD | -2683.736% |
Smith & Nephew plc | 2.17 Billion USD | 82.357% |
Sonendo, Inc. | 14.03 Million USD | -2634.15% |
STERIS plc | 3.12 Billion USD | 87.701% |
Stryker Corporation | 10.9 Billion USD | 96.48% |
Vapotherm, Inc. | 109.97 Million USD | -248.923% |
Zimmer Biomet Holdings, Inc. | 4.86 Billion USD | 92.117% |